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Delayed-Enhancement Cardiovascular
Magnetic Resonance Coronary Artery Wall Imaging
Comparison With Multislice Computed
Tomography and Quantitative Coronary Angiography
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Melvin Clouse, MD,† Pedro O. Martinezclark, MD,* Dana C. Peters, PHD,*
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Reza Nezafat, PHD,* David Maintz, MD,‡ Warren J. Manning, MD, FACC, FAHA,*†
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Boston, Massachusetts; and Muenster and Munich, Germany
Objectives We examined whether delayed-enhancement cardiovascular magnetic resonance (DE-CMR) coronary artery wall
imaging correlated with atherosclerosis detected by using multislice computed tomography (MSCT) and quanti-
tative coronary angiography (QCA).
Background The use of DE-CMR coronary vessel wall imaging may provide a noninvasive method to assess diseased coronary
vessel walls.
Methods We performed DE-CMR coronary artery wall imaging in 14 patients with cardiovascular risk factors and 6 healthy
subjects without risk factors.
Results A greater prevalence of strong DE was noted with greater MSCT evidence of disease, with DE in 2 (7%) of 30
coronary segments with no plaque by MSCT, in 1 (10%) of 10 segments with noncalcified plaque on MSCT, and
in 16 (36%) of 44 segments with calcifications by MSCT (p  0.009, adjusted p  0.035). Delayed enhance-
ment was observed in 8 (53%) of 15 segments with 20% coronary artery stenosis by QCA but also in 12 (15%)
of 80 segments without angiographically apparent coronary disease (p  0.004, adjusted p  0.01).
Conclusions The use of DE-CMR allowed us to identify areas of DE that correlate with severity of atherosclerosis by MSCT and
QCA. This novel approach may be useful for the assessment of coronary vessel wall in patients with suspected
coronary artery disease. (J Am Coll Cardiol 2007;50:441–7) © 2007 by the American College of Cardiology
Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.03.052i
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Pultislice computed tomography (MSCT) (1–4) and car-
iovascular magnetic resonance (CMR) imaging (5–7) have
merged as promising noninvasive imaging techniques for
oronary plaque visualization. Noncontrast CMR coronary
essel wall imaging enables the identification of thickened
oronary wall (5–7) but requires high spatial resolution
nd accurate motion correction. Contrast-enhanced CMR
ay provide an alternative because it is useful for evaluat-
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adiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston,
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ter, Germany; and the §Department of Nuclear Medicine, Technical University
unich, Munich, Germany. Dr. Clouse received $1,000 at the 11th Annual Spiral
T Conference, Las Vegas, September 2006, and Dr. Manning received $10,000
n research grant support from Philips Medical Systems.7
Manuscript received October 25, 2006; revised manuscript received March 15,
007; accepted March 28, 2007.ng carotid (8–11) and aortic (9,12) plaque. Delayed-
nhancement (DE) CMR (13) simplifies the imaging task
o detection of contrast uptake, thereby slightly reducing
patial resolution requirements. An earlier preliminary study
uggested that DE-CMR may be useful for coronary plaque
maging, although significance of findings in relation to
ther plaque assessment was not evaluated (14). In the
urrent study, we sought to determine whether DE-CMR
oronary vessel wall imaging findings correlate with athero-
clerosis detected by MSCT and quantitative coronary
ngiography (QCA). In addition, DE-CMR results for
ealthy control subjects were assessed.
ethods
atients. Fourteen subjects (age 63  9 years, range 46 to
6 years; 10 men) with one or more coronary risk factors
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Contrast-Enhanced CMR Coronary Artery Wall Imaging July 31, 2007:441–7(diabetes mellitus, hypertension,
hyperlipidemia, family history of
premature coronary artery dis-
ease, cigarette smoking) who had
undergone X-ray coronary an-
giography (CATH) and MSCT
were enrolled. In addition, 6
healthy control subjects (age 25 
7 years, range 19 to 33 years; 2
men) with no risk factors (and no
CATH or MSCT) were enrolled.
The study protocol was approved
by the institutional board on clin-
ical investigations at Beth Israel
eaconess Medical Center. Written informed consent was
btained from all subjects.
MR imaging. Subjects were scanned in the supine posi-
ion on a 1.5-T CMR scanner (Gyroscan ACS-NT, Philips
edical Systems, Best, the Netherlands) with 5-element
ardiac synergy coil and advanced cardiovascular software
ackage (R9.1).
oronary CMR imaging. Coronary MR angiography of
he right and left coronary artery systems were imaged using
previously described free-breathing electrocardiogram-
riggered 3-dimensional balanced steady-state free preces-
ion coronary magnetic resonance imaging sequence (15).
maging parameters included field of view  320 mm,
atrix  256  256, in-plane resolution  1.25  1.25
m, slice thickness  3 mm, acquisition window  80 to
00 ms, TR/TE  5.4 ms/2.7 ms, flip angle  110°, start
p cycles  5, and number of slices  12 to 15.
oronary artery wall imaging with DE-CMR. Ap-
roximately 60 min before vessel wall imaging, 0.2 mmol/kg
f gadolinium-DTPA (Magnevist, Berlex Laboratories,
ontville, New Jersey) was administered intravenously. We
erformed DE-CMR coronary artery wall imaging using a
atient Characteristics
Table 1 Patient Characteristics
Patient # Age (yrs) Gender Indication
1 46 Male Dyspnea, C
2 68 Male Severe aor
3 59 Male CP and E
4 47 Female CP and E
5 59 Male CP and E
6 66 Male DOE, fatigu
7 72 Female SOB and 
8 66 Male CP and E
9 70 Female CP and E
10 76 Male CP and E
11 59 Male ETT
12 62 Male ETT and
13 75 Male ETT and
14 58 Female CP and E
In addition, all patients had one or more coronary risk factors (see text). †MSCT highest plaque
CATH X-ray coronary angiography; CP chest pain; DE-CMR delayed enhancement-cardiova
Abbreviations
and Acronyms
CATH  X-ray coronary
angiography
CMR  cardiovascular
magnetic resonance
CNR  contrast-to-noise
DE  delayed enhancement
MSCT  multislice
computed tomography
QCA  quantitative
coronary angiographymoderate; MImyocardial infarction; MSCTmultislice computed tomography; NL normal; PCI
shortness of breath; VD  number of vessels with 20% stenosis in proximal to mid segments by QC1-weighted 3-dimensional gradient echo inversion recov-
ry sequence (3D IR TFE) (16,17). Imaging parameters,
ncluding imaging plane and voxel size, were identical to the
oronary MRI sequence, except for TR/TE  6.1/1.9 ms,
ip angle  30°, and an inversion RF pulse instead of
2prep for magnetization preparation (inversion time ad-
usted to null blood, typically 280 ms). Subjects with
isually evident coronary artery wall DE were asked to
eturn for a second imaging session (60 h after the first
can) for noncontrast (“native”) CMR vessel wall imaging
sing the same imaging parameters. Inversion time was
gain adjusted to null blood (typically inversion time
400 ms).
odeling of pharmacokinetics. To estimate T1 values
ver time, simulations were made based on earlier published
alues of plasma concentration of Gd-DTPA at various
ime points following intravenous injection in humans (18).
ontrast agent clearance from vessel wall was assumed to be
- to 5-fold slower than for blood, and plaque was modeled
o contain a blood fraction of 80%. The optimal inversion
ime for minimizing blood signal was estimated as a
unction of heart rate, contrast agent dose, and time after
njection using the T1 values derived from the simulation.
n 5 subjects, the results of the simulation were confirmed
y comparison with data obtained with a Look-Locker
equence (19). Similarly, the optimal imaging time point
fter contrast administration was derived by evaluating the
emporal behavior of blood to vessel wall contrast for
ifferent contrast doses.
SCT coronary angiography. Multislice computed to-
ography (for 11 subjects: 16-row, Aquilion 16, Toshiba
merica Medical Systems, Tustin, California; for 3 sub-
ects: 64-row, Aquilon 64) was performed after administra-
ion of 90 ml of nonionic contrast agent (ioversol, Optiray
50, Tyco Healthcare, Mansfield, Massachusetts). Subjects
ith heart rates 70 beats/min received intravenous meto-
ATH* QCA DE-CMR MSCT†
ETT 1VD S 3
nosis NL M 1
1VD M 1
NL M 1
2VD M 3
TT 2VD, 1 stent S 3
NL M 2
3VD S 3
NL S 1
2VD S 3
1VD S 3
MI 3VD, 2 stents S 3
PCI 3VD M 3
1VD M 3
ry: 1  noncalcified; 2  mildly calcified; 3  moderately to severely calcified.
magnetic resonance; DOE dyspnea on exertion;ETT reversible defect on nuclear stress test;for C
P and
tic ste
TT
TT
TT
e, E
ETT
TT
TT
TT
remote
remote
TT
catego
scularpercutaneous coronary intervention; QCA quantitative coronary angiography; S severe; SOB
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hickness  0.5 mm, field of view  320 mm, image matrix
12  512, pixel size 0.39 mm2, gantry rotation time 0.4 s,
35 kVp, 350 mA, and total scan time 16 to 24 s (3).
adiation dose was 11.4 mSv as calculated using IMPACT
oftware (IMPACT Scan, London, United Kingdom). Scan
arameters for 64-row imaging included slice thickness 0.5
m, field of view  320 mm, image matrix 512  512,
ixel size 0.39 mm2, gantry rotation time  0.4 s, 135 kVp,
50 mA with a total scan time of 8 to 9 s (3). Radiation dose
as 17.8 mSv as calculated using IMPACT software.
ATH. The subjects who had been referred for CATH by
heir treating physicians underwent conventional CATH
after MSCT and before DE-CMR) using standard tech-
iques with multiple projections (20).
mage analysis. Image analyses were performed for each of
coronary segments, including the left main, and the
Figure 1 Coronary MRI and Contrast-Enhanced Vessel Wall Sca
No enhancement was observed in any of the control subjects, suggesting the abse
onary systems were imaged. Note the trivial pericardial effusion (arrowheads) adja
enhancement cardiovascular magnetic resonance; LAD  left anterior descending corroximal and mid left anterior descending, left circumflex,
nd right coronary arteries. For uniform segment identifi-
ation, segments were predefined according to distance
rom coronary artery origin rather than by branch vessel
ocation.
E-CMR image analysis. The DE-CMR image analyses
ere performed by an investigator who was blinded to other
ata on multiplanar reformatted images using a previously
escribed analysis package (21). Contrast-to-noise (CNR)
etween coronary vessel wall and aortic blood (at the origin
f left main and right coronary artery) was determined.
egments were categorized quantitatively on a 3-point scale
ith 0 no (CNR2), 1 moderate (2 CNR7), and
 strong enhancement (CNR 7).
SCT image analysis. The MSCT images were analyzed
n a dedicated 3D workstation (Vitrea 2, Version 3.5 Vital
mages Inc, Plymouth, Minnesota). Images were recon-
r 4 Healthy Control Subjects Enrolled in the Study
f coronary atherosclerosis. Both the right (top rows) and left (bottom rows) cor-
o but distinguishable from the right coronary artery (RCA). DE-CMR  delayed-
rtery; LCX  left circumflex coronary artery; MRI  magnetic resonance imaging.ns fo
nce o
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Contrast-Enhanced CMR Coronary Artery Wall Imaging July 31, 2007:441–7tructed with slice thickness of 0.4 mm using a medium
harp convolution kernel at 10% intervals. Images were
eviewed by an observer who was blinded to other data
3,22). Automatic vessel detection with manual correction
as used to display multiplanar reformations and orthogo-
al cross-sectional coronary views (23). The presence and
ocation of noncalcified (130 HU), mildly to moderately
alcified (130 to 400 HU), and (400 HU) severely
alcified plaque was assessed (2,24).
CA analysis. QCA analysis was performed by an inde-
endent observer who was blinded to other data. These
nalyses were performed according to standard algorithms
o measure lesion stenosis with respect to mean reference
iameter (25).
tatistical analysis. The DE-CMR data were compared
ith the reference standards of presence of coronary plaque
etected by MSCT and 20% luminal narrowing by QCA.
he relationship between strong DE and the results of
CA and MSCT were evaluated using the Fisher exact
est, assuming independence of each vessel segment. Gen-
ralized estimating equations were used to adjust these
esults to account for correlation between repeated measure-
ents in the same individual. Continuous data are expressed
Figure 2 Data From a 46-Year-Old Subject With a Focal Lumina
Coronary magnetic resonance imaging (MRI) (A) and multislice computed tomogra
revealing a mixed calcified/noncalcified plaque. The corresponding X-ray angiogram
composition. In the lower row, a “hot spot” can be observed in the distal right cor
resonance (DE-CMR) vessel wall scan (E), which may be due to thrombus or hemo
(D). On the corresponding X-ray angiogram (C), an abrupt change in lumen diamet
(F), strong focal contrast uptake can be observed at the location of the proximal R
of the RCA where MSCT (B) reveals a mixed calcified/noncalcified plaque (dasheds mean  1 SD. Categorical data are expressed as counts
nd percentages. Continuous variables were compared using
2-tailed, paired, Student t test. A p value of 0.05 was used
o determine statistical significance.
esults
atient characteristics are summarized in Table 1. No
ubject had an acute coronary syndrome. All patients com-
leted DE-CMR, allowing for CMR assessment of 91
93%) of 98 coronary segments in 14 subjects (3 segments
ot evaluated because of the presence of stents, 4 segments
ot evaluated because of suboptimal image quality). A total
f 81 of these segments were able to be evaluated with
SCT. Suppression of blood signal (mean SNR  3.4 
.2; range 1.6 to 6.9) was good in most subjects (Figs. 1 to
), allowing good delineation of the vessel wall in patients
ith coronary artery disease (Figs. 2 and 3). No DE was
bserved in the coronary wall or thoracic aortic wall in any
f the healthy control subjects (Fig. 1).
Figures 2 and 3 show representative images comparing
MR, MSCT, and CATH and demonstrate the corre-
pondence of findings. In 2 (25%) of 8 patients with CMR
nosis in the Proximal RCA
SCT) (B) show evidence of focal plaque burden (white arrows), with MSCT
onfirms this finding without providing information with regard to plaque burden or
artery (RCA) on the precontrast delayed-enhancement cardiovascular magnetic
. Location of this spot is indicated on the identically formatted coronary MRI
be observed suggestive of occlusion and/or thrombus. On the DE-CMR image
enosis (solid white arrows). Another focal hotspot is present at the midsection
arrows). CATH  X-ray coronary angiography.l Ste
phy (M
(C) c
onary
rrhage
er can
CA st
white
c
f
(
i
a
i
w
h
e
s
i
C
w
n
c
s
a
a
(
M
c
c
D
t
n
r
445JACC Vol. 50, No. 5, 2007 Yeon et al.
July 31, 2007:441–7 Contrast-Enhanced CMR Coronary Artery Wall Imagingontrast enhancement and coronary artery disease risk
actors returning for native CMR vessel wall imaging, 3
5%) focal hyperintense areas were found on noncontrast
mages of 64 segments. On MSCT, 2 mildly to moderately
nd 1 severely calcified plaque was found at the correspond-
ng location. All locations of native hyperintensity correlated
ith 50% stenoses on QCA. Among the 11 of 14 patients
aving coronary artery wall DE, on average, 4.6 (66%) of 7
valuable coronary segments showed DE. There was progres-
ive increase in the prevalence of strong DE-CMR with
ncreasing MSCT atherosclerotic burden (Fig. 4). Strong
MR DE was noted in 2 (7%) of 30 coronary segments
ith no plaque by MSCT, in 1 (10%) of 10 segments with
oncalcified plaque, and in 16 (36%) of 44 segments with
alcificied plaque (p  0.009, adjusted p  0.035).
Strong CMR DE was observed in 8 (53%) of 15
egments with 20% coronary artery stenosis by QCA but
lso in 12 (15%) of 80 segments without angiographically
pparent coronary disease (p  0.004, adjusted p  0.01)
Fig. 5). Of 14 QCA stenotic segments evaluated by
SCT, 1 (7%) contained no detected plaque, 2 (14%)
ontained noncalcified plaque, 1 (7%) mildly to moderately
Figure 3 Patient Examples
A 59-year-old patient with no coronary disease demonstrated by X-ray evaluation. C
(MSCT) (D), and X-ray angiography (not shown) do not demonstrate coronary artery
trast images (B), whereas moderate diffuse enhancement of the left main (LM), le
was found on postcontrast delayed-enhancement cardiovascular magnetic resonan
shown) demonstrating evidence of disease in the proximal to mid-LCX. On MSCT,
(black arrows; MSCT performed before intervention). Coronary MRI (E) is limited b
(single black arrow; MRI performed after intervention). On noncontrast DE-CMR (F
arrows); these hyperintense regions also are present on postcontrast DE-CMR (G,
(G, white arrows).alcified plaque, and 9 (64%) severely calcified plaque.iscussion. In this study, we compared DE-CMR results
o coronary plaque detection by MSCT and 20% luminal
arrowing by QCA. In subjects with coronary atheroscle-
osis (20% lumen stenosis), DE-CMR coronary plaque
ry magnetic resonance imaging (MRI) (A), multislice computed tomography
se (A and D, black arrows). No focal enhancement was observed on noncon-
rior descending coronary artery (LAD), and left circumflex coronary artery (LCX)
-CMR) images (arrows) (C). (H) A 59-year-old patient with MSCT, and X-ray (not
d calcified/noncalcified LAD and a heavily calcified LCX plaque can be observed
presence of stents in the proximal to mid-LCX, which resulted in local signal loss
perintense areas are visible just distal to the LCX stents (white dashed
dashed arrows). Diffuse contrast uptake is present in the entire LM and LAD
Figure 4 Relationship Between Strong CMR
Contrast Enhancement and MSCT Plaque
Prevalence of DE-CMR contrast enhancement increases with severity of coro-
nary disease by MSCT along the spectrum from no plaque to noncalcified
plaque to calcified plaque. DE-CMR  delayed-enhancement cardiovascular
magnetic resonance; MR CE  magnetic resonance contrast enhancement;
MSCT  multislice computed tomography.orona
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Contrast-Enhanced CMR Coronary Artery Wall Imaging July 31, 2007:441–7maging enabled selective plaque visualization (8 of 15
egments; 53%) distinct from vessel wall depiction observed
ith native black blood coronary vessel wall imaging.
ontrast uptake was more often observed in calcified (36%)
han in noncalcified plaques (10%) or segments without
laque (7%). No DE-CMR vessel wall enhancement was
bserved in any healthy control subject. DE-CMR contrast
ptake may be associated with an increased distribution
olume (as with fibrosis and neovascularization) in the
ltered vessel wall or with increased vascular permeability (as
ay occur with inflammation).
istribution of coronary vessel wall DE-CMR. When
oronary segments were classified according to MSCT-
efined plaque type, there was a greater prevalence of strong
nhancement among segments with noncalcified plaques
han among segments without plaque and an even higher
revalence among calcified plaques. Segments with calcified
laques by MSCT were likely to display strong enhance-
ent (36%), but there were also a sizable minority of
SCT calcified segments that demonstrated no or only
oderate enhancement (36% and 27% respectively). Thus,
he sensitivity of DE-CMR to detected calcified plaque was
imited. Calcific elements may be superimposed upon fi-
rous plaque components developing with chronic vascular
nflammation. Such fibrous elements may be detected by
ontrast enhancement as has been demonstrated in carotid
isease (8,11).
Native hyperintensity was observed in 3 calcified plaques
y MSCT, which were all found to be stenotic (50%) on
CA. One explanation for this observation may be the
resence of mural or intraplaque thrombus containing
ethemoglobin, which is known to have a short T1
elaxation time (26). Of note, “native” imaging was per-
ormed 60 h after contrast injection. According to the
harmacokinetics of Gd-DTPA, a complete blood clear-
nce is expected after 400 min (18). Assuming a 5-fold
lower washout in coronary plaque, a complete clearance is
Figure 5 Relationship Between Strong DE-CMR Contrast
Enhancement and X-Ray Angiographic Disease
Prevalence of severe DE-CMR contrast enhancement is higher in the presence
of angiographic disease. CATH  X-ray coronary angiography; other abbrevia-
tions as in Figure 4.xpected after 34 h. However, the possibility that enhance-ent could persist at 60 h after Gd-DTPA injection
annot be excluded.
iffuse versus focal enhancement. In an autopsy study
27) of patients dying of acute myocardial infarction, diffuse
nd active coronary inflammation was found together with
ocal manifestations of atherothrombosis. In our study,
53% of coronary artery segments displayed at least mod-
rate DE, which is consistent with studies indicating the
iffuse nature of coronary artery disease (27,28). The DE-
MR technique may help assess coronary vessel wall
hanges which may be more widespread than luminal
esions.
ontrol group. DE-CMR was not observed in any of our
ealthy control subjects. This negative finding is in agree-
ent with the likely absence of coronary atherosclerosis in
oung subjects without cardiovascular risk factors.
tudy limitations. The number of subjects in this study is
mall. We did not compare DE-CMR with intravascular
ltrasound, which is the current in vivo gold standard for
oronary plaque assessment. However, intravascular ultra-
ound is an invasive technique with associated non-
egligible risks. Furthermore, no comparison with his-
opathologic data was performed. Another limitation of this
tudy is that some segments were not evaluable by CMR (7
f 98 segments [7%] and 10 of the remaining 91 segments
11%] were not evaluable by MSCT). The 10 segments that
ere unevaluable by MSCT were in 4 subjects studied by
6-row scans.
onclusions
e demonstrated successful application of DE-CMR for
laque visualization in the major epicardial coronary
rteries and demonstrate increasing prevalence of DE-
MR coronary artery wall contrast enhancement with
ncreasing severity of plaque calcification by MSCT and
orrelation with lumen stenosis by CATH. This ap-
roach may prove useful for the assessment of coronary
isease in patients with subclinical and advanced athero-
clerosis. Future work will be directed toward further
efining vessel wall characteristics in selected patient
roups and identifying clinical factors associated with
oronary wall contrast enhancement.
eprint requests and correspondence: Dr. Susan Yeon, Beth
srael Deaconess Medical Center, Cardiovascular Division, 330
rookline Avenue, Boston, Massachusetts 02215. E-mail: syeon@
idmc.harvard.edu.
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